Endocarditis  >>  Cubicin (daptomycin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00093067: Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Completed
3
NA
daptomycin
Cubist Pharmaceuticals LLC
Bacterial Endocarditis, Bacteremia
11/04
02/05
NCT00770341: A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Completed
3
122
NA
Daptomycin 4 mg/kg, MK3009, Comparator: vancomycin, Daptomycin 6 mg/kg
Merck Sharp & Dohme LLC
Staphylococcal Infection
02/10
02/10

Download Options